FAQs

FAQs for Consolidated Restricted Entities Lists Screening Tool

1) If an entity is not on one of the U.S. Government lists, is collaboration or other activity permissible?

Possibly, provided the collaboration complies with applicable U.S. laws, institutional policies, sponsor requirements, export control regulations, and disclosure obligations. However, the absence of an entity from a restricted-party list does not automatically mean a collaboration is risk-free or unrestricted. There are institutions that are not yet listed but which Federal Government agencies recognize as posing security risks. Researchers are expected to conduct appropriate due diligence and comply with all federal requirements. If you have a question about a potential collaboration or activity, please contact the Research Security Office.

2) Will collaboration with an entity on one or more of the lists limit my ability to receive an award from a federal funding agency?

Very likely. Collaborations with entities appearing on U.S. Government restricted-party lists may affect eligibility for certain federal awards, require additional agency review, or be prohibited under specific funding programs or award terms. Some agencies have adopted policies that prohibit federally funded collaborations with certain restricted entities altogether. Investigators should consult the Research Security Office before initiating or continuing such collaborations.

3) How far back do the risk reviews being conducted by federal funding agencies go?

There is no government-wide lookback period; however, the general period appears to be five years. Federal agencies generally evaluate the information required in grant applications, disclosures, current and pending support, institutional affiliations, and other information relevant to assessing research security risks. Reviews consider current and prior collaborations, including co-authorships, or activities if they are material to the review or to compliance with award requirements.

4) What if I started a collaboration prior to learning an entity is on one or more of the lists?

Researchers should promptly notify the Research Security Office. Do not assume that an existing collaboration may continue unchanged. The RSO can work with you to assess applicable restrictions, determine whether the collaboration must be modified or terminated, and advise on any required sponsor notifications or disclosures. Acting promptly after learning of the listing is important.

5) What if I started a collaboration with a researcher when he/she was at one institution but then moved to an entity on one of the lists?

Once the researcher becomes affiliated with a restricted entity, the collaboration should be reassessed. Continuing the collaboration may trigger sponsor restrictions, export control requirements, or institutional review, depending on the nature of the work and the funding source. Researchers should consult the Research Security Office before continuing the collaboration and, if necessary, modify or discontinue activities to remain compliant with applicable federal requirements.

 

Version 1, 14 August 2026